Navigation Links
Microbicides could serve to materialise women empowerment in the years to come

Microbicides are a broad range of user-controlled products that would help women protect themselves from sexually transmitted diseases including AIDS.// It can be developed in any form that is convenient to use such as a gel, cream, film or suppository.

These microbicides will enable women to negotiate condom use or to abandon partners who put them at risk and would also help avoid unwanted pregnancies, according to experts. With such products coming up, women empowerment will acquire new meaning in Tamil Nadu in a few months’ time when the third phase of the clinical trials for at least three candidate microbicides will begin. The Indian Council of Medical Research (ICMR), a premier research institution, is already studying a product called “Praneem”.

The existing violence, force and economic dependency render millions of women unable to negotiate condom use or abandon partners who put them at risk. This applies to all age group categories. Ultimately women end up with no choice but to give in. Furthermore, it is difficult to encourage male partners to use condoms.

There are currently no approved microbicides in large-scale use worldwide yet. In 2001, WHO declared nonoxylon-9 products, attempts of which turned out be a failure.

It is said that even 60 percent effective microbicides can prevent 2.5 million new HIV infections in the next three years, and this trial is important as the HIV vaccine is still 10 years away. Researchers world over are working on 60 products and half a dozen candidate microbicides are in the last stages of clinical trial, some in India.

In India, microbicide trials will be carried out by the ICMR in collaboration with an US research agency CONRAD, with which the central government has signed a MoU in 2004.

Source: Indo-Asian News Servic
'"/>




Page: 1

Related medicine news :

1. Computer Tool Predicts Effectiveness Of Microbicides
2. Microbicides, Need of the Hour, to Aid the Fight Against HIV
3. Virus Level could Predict Cervical Cancer Risk
4. Beware of the oral patch! It could be cancer!!!
5. Prozac miracle could end in disaster
6. Wonder drug - could end in disaster
7. Pollution could be a risk
8. Fright could be more harmful
9. Pregnant smokers could harm their child
10. Snoring could be a warning
11. Anthrax drug doxycycline could stunt fetal growth
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/23/2017)... ... , ... Scientists from the University of Exeter reported this month ... equivalent to a medium-paced run for pre-menopausal women, or a slow jog for post-menopausal ... spine care, I understand the importance exercise can play on improving bone health. Although ...
(Date:7/23/2017)... Fla. (PRWEB) , ... July 23, 2017 , ... ... M.D., has joined Florida Pain Relief Group – Melbourne, a practice owned by ... board certification in interventional pain management, Dr. Stern also is certified in pediatrics, ...
(Date:7/22/2017)... ... July 22, 2017 , ... The arthroscopic superior capsule ... opportunity to return to sports and jobs that require heavy physical work, as ... Annual Meeting in Toronto, Ontario, Canada. , “We studied 100 patients ...
(Date:7/21/2017)... Orange Park, FL (PRWEB) , ... July 21, ... ... that provides insurance management assistance and financial planning services to families and business ... in a charity event that promises to provide support to area adults with ...
(Date:7/21/2017)... ... , ... Hospital M&A activity slowed in the second quarter of 2017, according ... to 23 in the second quarter, up 15% from the 20 publicly announced acquisitions ... in the year-ago second quarter. Only four of the transactions disclosed a purchase price ...
Breaking Medicine News(10 mins):
(Date:7/6/2017)... , July 6, 2017 ThriveRx, the nutrition division of ... their families to thrive on nutrition support. To celebrate its ... new site has a fresh new look with improved organization to create ... ... ...
(Date:7/5/2017)... Oramed Pharmaceuticals Inc. (NASDAQ: ... clinical-stage pharmaceutical company focused on the development of oral drug ... the Israel Securities Authority to dual-list its common stock on ... commence trading on the TASE on July 12, 2017 under ... the Company, it is expected that Oramed will be included ...
(Date:7/5/2017)... , July 5, 2017   BioLife Solutions ... developer, manufacturer and marketer of proprietary clinical grade cell ... freeze media ("BioLife"), today announced that it has ... debt holder and largest shareholder, to modify its existing ... Pursuant to the modification, WAVI agreed to exchange its ...
Breaking Medicine Technology: